<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83856">
  <stage>Registered</stage>
  <submitdate>26/04/2009</submitdate>
  <approvaldate>21/05/2009</approvaldate>
  <actrnumber>ACTRN12609000325202</actrnumber>
  <trial_identification>
    <studytitle>Study for the development of new non-invasive methods for monitoring intracranial pressure using observation of the ocular retinal veins and optic disk.</studytitle>
    <scientifictitle>Study for the development of new non-invasive methods for monitoring intracranial pressure using observation of the ocular retinal veins and optic disk.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Raised intracranial pressure</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects who have invasive intracranial pressure monitors in place will have recordings of central retinal vein pulsation pressure by ophthalmodynomometry 4 times over 24 hours.</interventions>
    <comparator>central retinal vein pulsation pressure will be compared to intracranial pressure measurement.This will be done 4 times over 24 hours. The central retinal vein pulsation pressure will be ascertained by ophthalmodynomometry.</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>central retinal vein pulsation pressure by ophthalmodynomometry</outcome>
      <timepoint>over 24 hours during admission. 4 measurements.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>subjects who have intracranial pressure monitors in place who are conscious and able to provide informed consent.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>subjects who cannot sit up.
subjects who cannot tolerate mydriatic eye drops.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>27/04/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Sir Charles gairdner Hospital</primarysponsorname>
    <primarysponsoraddress>1 hospital Ave
Nedlands
Perth
Western Australia 6009</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Sam Kain</fundingname>
      <fundingaddress>Royal Perth Hospital
4 Wellington st
East Perth
Western Australia
6002</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>nil</sponsorname>
      <sponsoraddress>nil</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To try to develop a less risky method for measuring brain fluid pressure.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sir Charles Gairdner Hospital Ethics Committee</ethicname>
      <ethicaddress>1 hospital ave
Nedlands
Western Australia 6009</ethicaddress>
      <ethicapprovaldate>20/04/2009</ethicapprovaldate>
      <hrec>2009-024</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>WH Morgan</name>
      <address>2 Verdun St
Nedlands
Western Australia 6009</address>
      <phone>+61893810873</phone>
      <fax />
      <email>whmorgan@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>WH Morgan</name>
      <address>Lions Eye Institute
2 Verdun St
Nedlands 6009
Western Australia</address>
      <phone>+61893810873</phone>
      <fax />
      <email>whmorgan@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>